In summary, 15 cases presented with a loss of expression of Rb in the IHC assay, with a frequency of 66.7% (14/21) and 61.9% (13/21) in the NEC and non-NEC components, respectively. This evidence concerns the gene RB1 and neuroendocrine carcinoma.